A healthy volunteer study to test the safety and tolerability of a single dose of the Dexmedetomidine Transdermal System as well as how your body takes it in and disposes and breaks it down.
Phase 1
Completed
- Conditions
- Acute Pain Management in postoperative setting
- Registration Number
- ACTRN12618000205235
- Lead Sponsor
- Clinical Network Services Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Dexmedetomidine in transdermal drug delivery systems for acute pain management?
How does the Dexmedetomidine Transdermal System compare to standard-of-care analgesics in postoperative pain management?
What biomarkers are associated with the pharmacokinetics of Dexmedetomidine in healthy subjects?
What are the potential adverse events of single-dose Dexmedetomidine Transdermal System and how are they managed?
Are there any combination therapies involving Dexmedetomidine for enhanced postoperative pain relief?